Zenas BioPharma, Inc. (NASDAQ: ZBIO) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ZENAS BIOPHARMA, INC.

Zenas BioPharma, Inc. (NASDAQ: ZBIO)
Listen to this Section


$18.10
-0.2800 ( -1.52% ) 276.4K

Zenas BioPharma is a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need. We leverage our experienced executive management team and our established networks throughout the biopharmaceutical industry to identify, acquire and develop product candidates that we believe can provide superior clinical benefits to patients living with autoimmune diseases.

Market Data


Open $18.10
Previous Close $18.38
Volume 276.4K
Market Cap $1.16B
Day Range $17.79 - $18.91
52 Week Range $8.91 - $44.60
Shares Outstanding 63.13M
Change % -1.52%
Net Change ▼ -0.2800
Insider Ownership 0.55%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology
IPO Year2024
CountryUnited States
UnderwriterMorgan Stanley, Jefferies, Citi, Guggenheim Securities, more

Insider Ownership Transactions

Total Amount Purchased: 7,482,968.00

Date Type Amount Purchased Purchaser
2025-10-14 Buy 105265.00 ENRIGHT PATRICK G
2025-10-14 Buy 105265.00 ENRIGHT PATRICK G
2025-10-14 Buy 63158.00 SR ONE CAPITAL MANAGEMENT, LLC
2025-10-14 Buy 63158.00 Nunn Jason Raleigh
2025-10-09 Buy 36928.00 MOULDER LEON O JR
2025-10-09 Buy 316219.00 Fairmount Funds Management LLC
2025-10-09 Buy 36928.00 MOULDER LEON O JR
2024-12-04 Buy 25000.00 MOULDER LEON O JR
2024-11-20 Buy 7500.00 MOULDER LEON O JR
2024-09-20 Buy 10000.00 MOULDER LEON O JR

SEC Filings


Form Type Description Pages Date
8-k 8K-related 75 Oct 08, 2025
8-k 8K-related 14 Sep 02, 2025
10-q Quarterly Reports 75 Aug 12, 2025
8-k 8K-related 14 Aug 12, 2025
4 Insider transactions 1 Jun 12, 2025
4 Insider transactions 1 Jun 12, 2025
4 Insider transactions 1 Jun 12, 2025
4 Insider transactions 1 Jun 12, 2025
4 Insider transactions 1 Jun 12, 2025
4 Insider transactions 1 Jun 12, 2025

Latest News


× Before browsing our site, please accept our cookies policy